forbes top glp 1 companies ✅ just released their list of top-rated GLP-1 providers for 2025..., See how this online service compares in under 60 seconds 💊 | Health On Forbes How Lilly Used AI To

investor.lilly.com/news-releases/news-release-details/lillys-zepboundr-tirzepatide-superior-wegovyr-semaglutide-head Lincoff AM, Brown-Frandsen K, Colhoun HM, et al

Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by exendin-4: a translational case-control study

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes

This may include writing a prescription if they feel its necessary